• John O’Brien

    John currently works as a Global Biological Policy Intern at the Nuclear Threat Initiative. He holds a master’s of science in Biohazardous Threat Agents and Emerging Infectious Diseases from Georgetown University and a bachelor’s of science in bioengineering from George Mason University. His research interests include health security policy, counterterrorism, emerging biotechnology, and machine learning in health. John also received news that his project submission was accepted for the USDA/ABSA biosecurity and biosafety symposium in February. The submission was based on a project he did for Dr. Parker’s MICB 520 agroterrorism class, which is a core course required for our program. Read his ABSA poster here!

    Uncategorized

  • Sally Huang

    Sally Huang is a student in the Master’s in Biohazardous Threat Agents & Emerging Infectious Diseases program, from Fall 2018 to Spring 2019. She hopes to become an active member in the biodefense and national security field. Whether it is a full-time job, further education in a doctorate program, or both, she hopes to contribute new ideas and action to affect change in a world that is becoming increasingly vulnerable to advanced sciences and technology.

    Categories: Announcements, Student Profile

  • Rebecca Law

    Rebecca Law, a graduate of the M.S. Biohazardous Threat Agents & Emerging Infectious Diseases program, was a research assistant at START (the National Consortium for the Study of Terrorism and Responses to Terrorism) during her time in our program. She has recently published an article, All Along the Watchtower, which you may read more about here. Rebecca is currently employed in the CBRNE (chemical, biological, radiological, nuclear) Health and Security Division at Engility.

    Uncategorized

  • Global Security Depends on Matching Wits With Emerging Disease

    Researchers face a “perpetual challenge” to stay ahead of the evolving infectious microbes they seek to eradicate, said Anthony S. Fauci, MD, director of NIH’s National Institute of Allergy and Infectious Diseases, at a Georgetown symposium Feb. 19.

    Uncategorized